Carcinoma, Signet Ring Cell
Showing 1 - 25 of >10,000
Gastric Cancer, Signet Ring Cell Carcinoma Trial in Hangzhou (Without any intervention)
Active, not recruiting
- Gastric Cancer
- Signet Ring Cell Carcinoma
- Without any intervention
-
Hangzhou, Zhejiang, ChinaCancer Hospital of the University of Chinese Academy of Sciences
Aug 2, 2023
Colorectal Adenocarcinoma, Mucinous Adenocarcinoma, Signet Ring Cell Adenocarcinoma Trial in Trondheim, Lørenskog, Oslo
Not yet recruiting
- Colorectal Adenocarcinoma
- +2 more
-
Trondheim, Trondelag, Norway
- +2 more
Aug 15, 2022
Rectal Mucinous Adenocarcinoma, Rectal Signet Ring Cell Adenocarcinoma, Recurrent Rectal Carcinoma Trial in Houston (drug,
Terminated
- Rectal Mucinous Adenocarcinoma
- +8 more
- Capecitabine
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Nov 21, 2022
Adenoid Cystic Skin Carcinoma, Adnexal Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative Trial in United States
Recruiting
- Adenoid Cystic Skin Carcinoma
- +38 more
- Biopsy
- +6 more
-
Los Angeles, California
- +35 more
Jan 31, 2023
Signet Ring Cell Gastric Adenocarcinoma Trial in Lille cedex (peri-operative chemo, Surgery first)
Recruiting
- Signet Ring Cell Gastric Adenocarcinoma
- peri-operative chemotherapy
- Surgery first
-
Lille cedex, FranceGeneral and digestive surgical department, Claude Huriez Hospita
Mar 25, 2021
Acinar Cell Adenocarcinoma of the Pancreas, Adenocarcinoma of the Gallbladder, Adenocarcinoma of Unknown Primary Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +39 more
- oxaliplatin
- +4 more
-
Chicago, Illinois
- +1 more
May 7, 2020
Prostate Cancer, Prostate Adenocarcinoma, Prostatic Tumors Trial in Istanbul (Performing cognitive prostate biopsy with a
Recruiting
- Prostate Cancer
- +4 more
- Performing cognitive prostate biopsy with a radiologist's guidance with map
- Performing cognitive prostate biopsy without a radiologist's guidance with map
-
Istanbul, TurkeyMarmara University, School of Medicine, Department of Urology
Jun 5, 2023
Poorly Differentiated Adenocarcinoma With Signet Ring Cells of
Completed
- Gallbladder Cancer
- laparoscopic whole-layer cholecystectomy
-
Ōita, Oita, Japanoita Red Cross hospital
Sep 24, 2022
Gastric Adenocarcinoma Trial in France, Spain (HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) with oxaliplatin, Curative
Active, not recruiting
- Gastric Adenocarcinoma
- HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) with oxaliplatin
- Curative gastrectomy
-
Amiens, France
- +32 more
Jan 26, 2022
Proximal Gastric Adenocarcinoma, Reconstruction Trial in Shanghai (Double tract reconstruction, Gastric conduit reconstruction,
Recruiting
- Proximal Gastric Adenocarcinoma
- Reconstruction
- Double tract reconstruction
- +2 more
-
Shanghai, Shanghai, ChinaZhongshan Hospital Fudan University
Sep 13, 2022
Fibroblast Activation Protein Inhibitor PET/CT Imaging in
Recruiting
- Gastrointestinal Cancer
- Fibroblast activation protein inhibitor PET/CT imaging
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Jul 14, 2022
Rectal Mucinous Adenocarcinoma, Rectal Signet Ring Cell Adenocarcinoma, Recurrent Rectal Carcinoma Trial in Boston
Completed
- Rectal Mucinous Adenocarcinoma
- +10 more
- Radiotherapy
- +4 more
-
Boston, MassachusettsEastern Cooperative Oncology Group
Dec 3, 2018
Fibroblast Activation Protein Inhibitor, PET/CT, Malignant Tumor Trial in Wuhan (68Ga-FAPI, PET/CT)
Recruiting
- Fibroblast Activation Protein Inhibitor
- +2 more
- 68Ga-FAPI
- PET/CT
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Aug 27, 2021
Squamous Cell Carcinoma of Oral Cavity, Pharynx Carcinoma, Larynx Carcinoma Trial in Gliwice (Chemotherapy
Recruiting
- Squamous Cell Carcinoma of Oral Cavity
- +3 more
- Chemotherapy (carboplatin+paclitaxel) with concomitant low dose ionizing radiotherapy
-
Gliwice, Silesia, PolandThe Maria Sklodowska-Curie National Research Institute of Oncolo
Aug 7, 2023
Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)
Recruiting
- Renal Cell Carcinoma
- 68Ga-NY104 PET/CT
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 5, 2023
Squamous Cell Carcinoma of Head and Neck, Basal Cell Carcinoma of Skin Trial in Vandœuvre-lès-Nancy (microscopy confocal
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
- Basal Cell Carcinoma of Skin
- microscopy confocal (Histolog Scanner)
-
Vandœuvre-lès-Nancy, FranceGilles Dolivet
Jul 7, 2023
The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC Trial in Hanzhou (Cadonilimab Combined Albumin-paclitaxel,
Recruiting
- The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC
- Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil
-
Hanzhou, Zhejiang, ChinaLulu Liu
Jul 14, 2023
Squamous Cell Carcinoma of the Skin Trial in Zhengzhou (Carrilizumab with albumin-binding paclitaxel)
Not yet recruiting
- Squamous Cell Carcinoma of the Skin
- Carrilizumab with albumin-binding paclitaxel
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
May 23, 2023
Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)
Not yet recruiting
- Clear Cell Renal Cell Carcinoma
- 68Ga-NY104 PET/CT
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
May 18, 2023
Metastatic Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)
Not yet recruiting
- Metastatic Clear Cell Renal Cell Carcinoma
- 68Ga-NY104 PET/CT
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
May 18, 2023
Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,
Recruiting
- Esophageal Squamous Cell Carcinoma
- Head and Neck Squamous Cell Carcinoma
- Camrelizumab
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Oct 25, 2023
Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (Radiotherapy, Toripalimab)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
- Radiotherapy
- Toripalimab
- (no location specified)
Mar 17, 2023
Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1
Recruiting
- Metastatic Esophageal Squamous Cell Carcinoma
- TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors(Sintilimab)
-
Qingdao, Shandong, China
- +1 more
Nov 13, 2023
Urologic Cancer Trial in Taipei
Recruiting
- Urologic Cancer
-
Taipei, TaiwanYu wei-lan
Feb 2, 2023